Current status of ESKAPE microorganisms in Spain: epidemiology and resistance phenotypes
Rev. esp. quimioter
; 32(supl.2): 27-31, sept. 2019. graf
Artigo
em Inglês
| IBECS
| ID: ibc-188735
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
Resistance rates in ESKAPE microorganisms included in the EARS-net surveillance database from Spain have increased in most of the cases. In 2017, multi-drug resistant isolates rose to 5.5% in Escherichia coli and 13.0% in Klebsiella pneumoniae. Carbapenemase producing Enterobacterales (CPE) have also increased in Spain over the last years with a current spread of throughout the country. EuSCAPE project revealed dominance of OXA-48 carbapenemase with lower prevalence of KPC, VIM or NDM enzymes. Increase of faecal carriers and presence of carbapenemases in the so-called high-risk clones have boosted the persistence and dissemination of CPE. One of these clones, the ST307 K. pneumoniae, has been associated with the spread of KPC carbapenemases and emergence of KPC variants conferring resistance to ceftazidime-avibactam combination
RESUMEN
No disponible
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Infecções Bacterianas
/
Infecção Hospitalar
/
Farmacorresistência Bacteriana
Limite:
Humanos
País/Região como assunto:
Europa
Idioma:
Inglês
Revista:
Rev. esp. quimioter
Ano de publicação:
2019
Tipo de documento:
Artigo
Instituição/País de afiliação:
Hospital Universitario Ramón y Cajal/Spain